Latest News Releases From The Newsroom
Breaking: SmileDirectClub Seeks Chapter 11 Relief
September 30th, 2023
SmileDirectClub, Inc. (Nasdaq: SDC) has unveiled plans for a significant recapitalization effort, aimed at fortifying the company's financial foundation and supporting future growth as a global leader in oral care. The recapitalization will involv. Read more
OpGen and Femasys: Pre-Market Action Unveiled
September 29th, 2023
Shares of OpGen, Inc. (Nasdaq: OPGN) surged by more than 100% in pre-market trading following a regulatory filing with the Securities and Exchange Commission (SEC), requesting the SEC's consent to withdraw the company's Registration Statement on Form. Read more
Breaking: UK's CMA OKs £1.2bn UnitedHealth-EMIS Deal
September 29th, 2023
The Competition and Markets Authority (CMA) has given the green light to the £1.2 billion acquisition deal between healthcare tech companies UnitedHealth Group Inc. (NYSE: UNH) and EMIS, both of which provide critical services to the UK's Natio. Read more
Novo Integrated and Northrop Grumman: Breakthrough Mega Deals
September 29th, 2023
Shares of Novo Integrated Sciences, Inc. (Nasdaq: NVOS) surged by more than 100% in after-hours trading following the company's announcement of a significant development. Novo and Blacksheep Trust have finalized a One Billion Dollar Master Collateral. Read more
Earnings Reactions: NIKE and BlackBerry Post Mixed Results
September 28th, 2023
NIKE, Inc. (NYSE: NKE), a prominent sportswear and athletic equipment company, reported first-quarter fiscal 2024 earnings of $0.94 per share, surpassing the consensus EPS estimate of $0.74. Quarterly revenues for the company amounted to $12.9 billio. Read more
Setback for BrainStorm Cell Therapeutics; Accenture Posts Mixed Results
September 28th, 2023
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more
Momentum Builds: Gritstone bio's BARDA Contract; Peloton's Lululemon 5-Year Pact
September 28th, 2023
Shares of Gritstone bio, Inc. (Nasdaq: GRTS) soared over 40% in after-hours trading following the company's announcement of an up to $433 million contract awarded by the Biomedical Advanced Research and Development Authority (BARDA). The contra. Read more
Micron Technology Beats Estimates, Guidance Disappoints
September 27th, 2023
Micron Technology, Inc. (Nasdaq: MU), a renowned semiconductor company, reported a loss of $(1.07) per share for the fourth quarter of fiscal 2023, better than the consensus estimate loss of $(1.18). The company's quarterly revenues reached $4.01 bil. Read more
FTC Sues Amazon for Illegally Maintaining Monopoly Power
September 27th, 2023
Amazon’s ongoing pattern of illegal conduct blocks competition, allowing it to wield monopoly power to inflate prices, degrade quality, and stifle innovation for consumers and businesses Washington D.C. / CRWE PRESS RELEASE / September 26, 2. Read more
Bullish View On Blink Charging; Pfizer Deal Boosts Ginkgo Bioworks
September 27th, 2023
UBS has initiated coverage on Blink Charging Co. (Nasdaq: BLNK), a leading provider of electric vehicle charging services, with a Buy rating and a price target of $7. With $BLNK closing at $2.93 on Tuesday, the price target suggests a significant . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login